View Document Preview and Link Document Date: 2012-07-31 03:18:13 Open Document File Size: 60,80 KB Share Result on Facebook
City Denver / ORP / SAN DIEGO / / Company Therapeutics Inc. / OrPro / / Currency USD / / Facility University of Colorado Denver/Children / Hospital Colorado / hospital National Jewish Health / / IndustryTerm stage biopharmaceutical / thioredoxin active site / treatment of pulmonary disease / adhesive protein gel network / biologics manufacturing / Treatment of Cystic Fibrosis / / MedicalCondition immune and related disorders / disease / COPD/emphysema / pulmonary disease / inherited genetic disease / diseases / obstructive pulmonary diseases / bronchiectasis / cystic fibrosis / chronic infection / severe asthma / serious obstructive pulmonary diseases / disorders / / MedicalTreatment antibiotic therapy / / Organization National Institute of Health / University of Colorado / / Person Heifetz / White / Raser / / Position chief operating officer / principal investigator / medical advisors / president and chief technology officer / / ProvinceOrState California / Colorado / / PublishedMedium U.S. News & World Report / / SocialTag 
OrPro
Therapeutics
Receives
NIH
Grant
Award
to
Advance
Development
of
Recombinant
Thioredoxin
for
Treatment